These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24323359)

  • 21. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch2-dependent DC2s mediate splenic germinal center responses.
    Briseño CG; Satpathy AT; Davidson JT; Ferris ST; Durai V; Bagadia P; O'Connor KW; Theisen DJ; Murphy TL; Murphy KM
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10726-10731. PubMed ID: 30279176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes.
    Moran ST; Cariappa A; Liu H; Muir B; Sgroi D; Boboila C; Pillai S
    J Immunol; 2007 Jul; 179(1):195-200. PubMed ID: 17579038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch2 regulates the development of marginal zone B cells through Fos.
    Iwahashi S; Maekawa Y; Nishida J; Ishifune C; Kitamura A; Arimochi H; Kataoka K; Chiba S; Shimada M; Yasutomo K
    Biochem Biophys Res Commun; 2012 Feb; 418(4):701-7. PubMed ID: 22293205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells.
    Witt CM; Won WJ; Hurez V; Klug CA
    J Immunol; 2003 Sep; 171(6):2783-8. PubMed ID: 12960298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8.
    Xu H; Chaudhri VK; Wu Z; Biliouris K; Dienger-Stambaugh K; Rochman Y; Singh H
    Nat Immunol; 2015 Dec; 16(12):1274-81. PubMed ID: 26437243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
    Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G
    J Exp Med; 2012 Aug; 209(9):1537-51. PubMed ID: 22891273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone Arginine Methylation by PRMT7 Controls Germinal Center Formation via Regulating Bcl6 Transcription.
    Ying Z; Mei M; Zhang P; Liu C; He H; Gao F; Bao S
    J Immunol; 2015 Aug; 195(4):1538-47. PubMed ID: 26179907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.
    Wang JH; Li J; Wu Q; Yang P; Pawar RD; Xie S; Timares L; Raman C; Chaplin DD; Lu L; Mountz JD; Hsu HC
    J Immunol; 2010 Jan; 184(1):442-51. PubMed ID: 19949066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA00492 is required for marginal zone B-cell development.
    Wang F; Cui D; Zhang Q; Shao Y; Zheng B; Chen L; Luo Y; Yuan L; Wang D
    Immunology; 2022 Jan; 165(1):88-98. PubMed ID: 34435359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.
    Yu J; Zanotti S; Schilling L; Schoenherr C; Economides AN; Sanjay A; Canalis E
    Am J Pathol; 2018 Jun; 188(6):1430-1446. PubMed ID: 29545197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marginal Zone Formation Requires ACKR3 Expression on B Cells.
    Radice E; Ameti R; Melgrati S; Foglierini M; Antonello P; Stahl RAK; Thelen S; Jarrossay D; Thelen M
    Cell Rep; 2020 Aug; 32(5):107951. PubMed ID: 32755592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
    Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
    Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development.
    Wu L; Maillard I; Nakamura M; Pear WS; Griffin JD
    Blood; 2007 Nov; 110(10):3618-23. PubMed ID: 17699740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice.
    Stolp J; Mariño E; Batten M; Sierro F; Cox SL; Grey ST; Silveira PA
    J Immunol; 2013 Jul; 191(1):97-109. PubMed ID: 23740954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
    Valls E; Lobry C; Geng H; Wang L; Cardenas M; Rivas M; Cerchietti L; Oh P; Yang SN; Oswald E; Graham CW; Jiang Y; Hatzi K; Agirre X; Perkey E; Li Z; Tam W; Bhatt K; Leonard JP; Zweidler-McKay PA; Maillard I; Elemento O; Ci W; Aifantis I; Melnick A
    Cancer Discov; 2017 May; 7(5):506-521. PubMed ID: 28232365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gα
    Hwang IY; Boularan C; Harrison K; Kehrl JH
    Front Immunol; 2018; 9():687. PubMed ID: 29696016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen.
    Guo F; Weih D; Meier E; Weih F
    Blood; 2007 Oct; 110(7):2381-9. PubMed ID: 17620454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.